NYLI Fiera SMID Growth Class A (APSRX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
14.01
+0.36 (2.64%)
Apr 22, 2025, 4:00 PM EDT
-13.84% (1Y)
Fund Assets | 108.54M |
Expense Ratio | 1.30% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 0.50 |
Dividend Yield | 3.44% |
Dividend Growth | n/a |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 5, 2024 |
Previous Close | 13.65 |
YTD Return | -15.35% |
1-Year Return | -11.45% |
5-Year Return | 66.99% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 85 |
Inception Date | Feb 12, 2018 |
About APSRX
The NYLI Fiera SMID Growth Class A (APSRX) seeks to achieve long-term capital growth. APSRX seeks to achieve its investment objective by investing in a diversified portfolio of common stocks of small and mid cap growth-oriented companies that are selected for their long term capital appreciation & which are expected to grow faster than the US economy.
Category Mid-Cap Growth
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol APSRX
Share Class Class A
Index Russell 2500 Growth TR
Performance
APSRX had a total return of -11.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.70%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
Symbol | Share Class | Expense Ratio |
---|---|---|
APSGX | Class I | 1.05% |
Top 10 Holdings
22.65% of assetsName | Symbol | Weight |
---|---|---|
argenx SE | ARGX | 3.03% |
BWX Technologies, Inc. | BWXT | 2.81% |
Mainstay Funds Trust - Main US Government Liquidity Fund | MUSXX | 2.57% |
Tyler Technologies, Inc. | TYL | 2.24% |
Stifel Financial Corp. | SF | 2.11% |
GitLab Inc. | GTLB | 2.10% |
SpringWorks Therapeutics, Inc. | SWTX | 2.06% |
Expedia Group, Inc. | EXPE | 1.95% |
JFrog Ltd. | FROG | 1.90% |
MongoDB, Inc. | MDB | 1.88% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 5, 2024 | $0.49679 | Dec 5, 2024 |
Dec 5, 2023 | $0.41528 | Dec 5, 2023 |